Generics and Biosimilars Initiative (GaBI)
Generics and Biosimilars Initiative (GaBI)
4 FOLLOWERS
Generics and Biosimilars Initiative (GaBI) was founded in 2008 by Pro Pharma Communications International. Its mission is to foster the worldwide efficient use of high-quality and safe medicines at an affordable price, thus advancing and supporting the idea of accessible, affordable, and sustainable health care.
Budget impact analysis of Rixathon introduction in Chile for non-Hodgkin lymphoma
Generics and Biosimilars Initiative (GaBI)
by
1w ago
..read more
Visit website
FDA approves filgrastim biosimilar Nypozi
Generics and Biosimilars Initiative (GaBI)
by
1w ago
..read more
Visit website
Biosimilars in inflammatory bowel disease: are we ready for multiple switches
Generics and Biosimilars Initiative (GaBI)
by
3w ago
..read more
Visit website
FDA approves third aflibercept biosimilar Ahzantive
Generics and Biosimilars Initiative (GaBI)
by
3w ago
..read more
Visit website
China approves Simcare’s cetuximab beta Enlituo
Generics and Biosimilars Initiative (GaBI)
by
1M ago
..read more
Visit website
Humira's resilience in the face of biosimilar competition
Generics and Biosimilars Initiative (GaBI)
by
1M ago
..read more
Visit website
Richmond to launch similar biologicals bevacizumab Yriviak and adalimumab Armixa
Generics and Biosimilars Initiative (GaBI)
by
1M ago
..read more
Visit website
Topline results from clinical development programme for candidate biosimilar AVT05 golimumab
Generics and Biosimilars Initiative (GaBI)
by
1M ago
..read more
Visit website
EC biosimilar approvals: Omlyclo, Jubbonti/Wyost, and Pyzchiva
Generics and Biosimilars Initiative (GaBI)
by
2M ago
..read more
Visit website
FDA approves first eculizumab biosimilar Bkemv for two rare diseases
Generics and Biosimilars Initiative (GaBI)
by
2M ago
..read more
Visit website

Follow Generics and Biosimilars Initiative (GaBI) on FeedSpot

Continue with Google
Continue with Apple
OR